December 9, 2009
Vitamin D linked to surviving lymphoma
U.S. researchers found vitamin D levels are associated with survival in lymphoma patients. Lead investigator Dr. Matthew Drake of the Mayo Clinic in Rochester, Minn., said the research team tracked 374 patients enrolled in the University of Iowa /Mayo Clinic Lymphoma Specialized Program of Research Excellence, who had been diagnosed with diffuse large B-cell […]
December 9, 2009
ASH: Drug Combo Active in Relapsed Mantle-Cell Lymphoma
Half of patients with relapsed or refractory mantle-cell lymphoma achieved major responses when treated with the investigational agent temsirolimus and rituximab (Rituxan), data from an ongoing clinical study showed. Responses persisted for almost 10 months and demonstrated durability in rituximab-refractory patients, according to Stephen M. Ansell, MD, of the Mayo Clinic in Rochester, Minn. […]
December 8, 2009
Vitamin D May Boost Lymphoma Survival
Healthy levels of vitamin D may help patients with a certain type of non-Hodgkin’s lymphoma live longer. Researchers at the Mayo Clinic have discovered that patients with diffuse large B-cell lymphoma (DLBCL) and low vitamin D levels are two times more likely to die from the cancer than patients with optimal levels. Deficient vitamin D […]
December 8, 2009
Patients deficient in vitamin D fare worse in battle with lymphoma
A shortage of vitamin D may stack the deck against people fighting a common form of lymphoma, researchers reported December 5 at a meeting of the American Society of Hematology. The new study adds this cancer to the list of malignancies suspected of being more difficult to control in patients with vitamin D deficiency common […]